Kit for determining glycocholic acid in human blood

A technology of glycocholic acid and a kit, which is applied in the field of kits for measuring glycocholic acid in human blood, can solve the problems of cumbersome operation, slow measurement speed, lack of reagents and the like, and achieves simple inspection operation, slow measurement speed and good sensitivity. Effect

Active Publication Date: 2013-03-06
浙江强盛生物科技有限公司
View PDF4 Cites 41 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] 1. Elisa assay method: This method is generally used for semi-quantitative assays, and its accuracy, sensitivity, and precision are poor, and the operation is cumbersome, which is not conducive to Widely used in clinical
[0005]2. Chemiluminescence measurement method: This method has high sensitivity, but the measurement accuracy and reagent stability are poor, and special chemiluminescence measure

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] A test kit for measuring glycocholic acid in human blood, comprising reagent A, reagent B and a known concentration of glycocholic acid calibrator, wherein the mass ratio of reagent A to reagent B is 5: 1;

[0036] Each component of described reagent A and content thereof are as follows:

[0037] Microbial inhibitor (sodium azide) 0.001g / L, EDTA 5.0 g / L, glycerol 0.1 g / L, bovine serum albumin 5.0g / L, surfactant (Tween20) 3.0g / L, reaction enhancer (poly Ethylene glycol 2000) 0.5g / L, sodium chloride 8.0g / L, pH 6 phosphate buffer 25mmol / L.

[0038] Each component and content thereof of described reagent B are as follows:

[0039] Microbial inhibitor (sodium azide) 0.001g / L, EDTA 5.0 g / L, glycerol 0.1 g / L, bovine serum albumin 5.0g / L, surfactant (Tween20) 3.0g / L, reaction enhancer (poly Ethylene glycol 2000) 0.5g / L, sodium chloride 8.0g / L, pH 6 phosphate buffer 25mmol / L, nano-microspheres cross-linked with glycocholic acid monoclonal antibody with a particle size of 50nm ...

Embodiment 2

[0050] A test kit for measuring glycocholic acid in human blood, comprising reagent A, reagent B and a known concentration of glycocholic acid calibrator, wherein the mass ratio of reagent A to reagent B is 4: 1;

[0051] Each component of described reagent A and content thereof are as follows:

[0052] Microbial inhibitor (ProClin 200) 0.5g / L, EDTA 2.0 g / L, glycerol 5 g / L, bovine serum albumin 2.0g / L, surfactant (Tween30) 1.0g / L, reaction enhancer (polyethylene Diol 4000) 2g / L, sodium chloride 3.0g / L, pH 7 glycine buffer 50mmol / L.

[0053] Each component and content thereof of described reagent B are as follows:

[0054] Microbial inhibitor (ProClin 200) 0.5g / L, EDTA 2.0 g / L, glycerol 5 g / L, bovine serum albumin 2.0g / L, surfactant (Tween30) 1.0g / L, reaction enhancer (polyethylene Glycol 4000) 2g / L, sodium chloride 3.0g / L, glycine buffer solution at pH 7 50mmol / L, and nano-microspheres cross-linked with glycocholic acid monoclonal antibody with a particle size of 80nm is 0.2...

Embodiment 3

[0064] A test kit for measuring glycocholic acid in human blood, comprising reagent A, reagent B and a known concentration of glycocholic acid calibrator, wherein the mass ratio of reagent A to reagent B is 1:1;

[0065] Each component of described reagent A and content thereof are as follows:

[0066] Microbial inhibitor (ProClin 300) 1.1g / L, EDTA 0.05 g / L, glycerin 10 g / L, bovine serum albumin 1.0g / L, surfactant (Tween80) 0.01g / L, reaction enhancer (polyethylene Diol 8000) 5.0g / L, sodium chloride 0.1g / L, pH 8 N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid buffer 100mmol / L.

[0067] Each component and content thereof of described reagent B are as follows:

[0068] Microbial inhibitor (ProClin 300) 1.1g / L, EDTA 0.05 g / L, glycerin 10 g / L, bovine serum albumin 1.0g / L, surfactant (Tween80) 0.01g / L, reaction enhancer (polyethylene Diol 8000) 5.0g / L, sodium chloride 0.1g / L, pH 8 N-tris(hydroxymethyl)methyl-3-aminopropanesulfonic acid buffer 100mmol / L, and glycocholic aci...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to view more

Abstract

The invention discloses a kit for determining glycocholic acid in human blood. The kit comprises a reagent A, a reagent B and a calibrator for glycocholic acid with known concentration, wherein the mass ratio of the reagent A to the reagent B is (1-5):1; the reagent A comprises a microorganism inhibiting agent, EDTA (Ethylene Diamine Tetraacetic Acid), glycerol, albumin bovine serum, a surface active agent, a reactive reinforcing agent, sodium chloride and a Good's buffer solution with the pH of 6-8; and the reagent B comprises the microorganism inhibiting agent, the EDTA (Ethylene Diamine Tetraacetic Acid), the glycerol, the albumin bovine serum, the surface active agent, the reactive reinforcing agent, sodium chloride, the Good's buffer solution with the pH of 6-8 and nanoparticles crosslinked with a glycocholic acid monoclonal antibody. The kit is simple, convenient and fast in detection and operation, can be used for simultaneously and quickly determining a large amount of samples and has good detection accuracy and sensitivity.

Description

technical field [0001] The invention relates to an immunoassay kit, in particular to a kit for measuring glycocholic acid in human blood. Background technique [0002] Cholyglycine (CG) is a conjugated bile acid formed by combining bile acid and glycine. Cholic acid (CA) and chenodeoxycholic acid (CDCA) are collectively referred to as bile acids. Among the biochemical indicators of liver injury, CG is more sensitive than alanine aminotransferase, bilirubin and other tests. In acute hepatitis, chronic active hepatitis, primary liver cancer, liver cirrhosis and chronic persistent hepatitis, the levels of serum CG were higher than those in the normal control group, and the positive rate increased in descending order. Especially in the clinical differentiation of chronic active hepatitis and chronic persistent hepatitis, CG can be used as a valuable indicator, and the amplitude and frequency of CG elevation in chronic active liver are higher than those in chronic migratory liv...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/577G01N33/531
Inventor 黄信用
Owner 浙江强盛生物科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap